VIVOS THERAPEUTICS INC (VVOS) Stock Institutional Trading Activity


VIVOS THERAPEUTICS INC (VVOS) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q1 2026), investors with some of the largest reported share count changes include Sequoia Financial Advisors and Renaissance Technologies LLC. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q1 2026Sequoia Financial AdvisorsBuy24,00024,000$28,320
Q3 2025Renaissance Technologies LLCBuy39,27939,279$121,765

Frequently asked questions about VVOS activity

  • Which institutional owners are buying VVOS?

    Institutional owners buying VVOS include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in VVOS activity?

    "Buy" means an investor increased their reported position in VVOS compared to the prior reporting period. This reflects growing exposure to VIVOS THERAPEUTICS INC (VVOS) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in VVOS increasing?

    Institutional interest in VVOS can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.